Another mistake over GM technology

Two years ago, biotechnology business Monsanto received a bloody nose over its attempts to introduce genetically modified crops and foods into Europe. Across much of the continent the perception was that the company was seeking to foist an unsettling new technology on an unreceptive and unprepared public. Monsanto and other biotechnology businesses have paid dearly for their errors - and the price is rising as a major market remains largely closed to their products and research and development costs accumulate.

Sorry you do not have access to this article. Please contact Customer Support at
or call 020 8267 8120

The ENDS Report - subscribe today